Skip to content

Advertisement

Botanical Studies

An International Journal

Botanical Studies Cover Image
  • Research
  • Open Access

Lemon protein disulfide isomerase: cDNA cloning and biochemical characterization

  • †2,
  • †3,
  • †1,
  • †4 and
  • 1Email author
†Contributed equally
Botanical StudiesAn International Journal201354:34

https://doi.org/10.1186/1999-3110-54-34

©  Chen et al.; licensee Springer. 2013

Received: 27 May 2013

Accepted: 12 September 2013

Published: 16 September 2013

Abstract

Background

Protein disulfide isomerases (PDIs), a family of structurally related enzymes, aid in protein folding by catalyzing disulfide bonds formation, breakage, or isomerization in newly synthesized proteins and thus.

Results

A ClPDI cDNA (1828 bp, GenBank accession HM641784) encoding a putative PDI from Citrus limonum was cloned by polymerase chain reaction (PCR). The DNA sequence encodes a protein of 500 amino acids with a calculated molecular mass of 60.5 kDa. The deduced amino acid sequence is conserved among the reported PDIs. A 3-D structural model of the ClPDI has been created based on the known crystal structure of Homo sapiens (PDB ID: 3F8U_A). The enzyme has two putative active sites comprising the redox-active disulfides between residues 60–63 and 405–408 (motif CGHC). To further characterize the ClPDI, the coding region was subcloned into an expression vector pET-20b (+), transformed into E. coli Rosetta (DE3)pLysS, and recombinant protein expressed. The recombinant ClPDI was purified by a nickel Sepharose column. PDI’s activity was assayed based on the ability of the enzyme to isomerize scrambled RNase A (sRNase A) to active enzyme. The KM, kcat and kcat/KM values were 8.3 × 10-3 μM, 3.0 × 10-5 min-1, and 3.6 × 10-1 min-1 mM-1. The enzyme was most active at pH 8.

Conclusions

The advantage of this enzyme over the PDI from all other sources is its low KM. The potential applications of this PDI in health and beauty may worth pursuing.

Keywords

  • Citrus limonum
  • Protein disulfide isomerase (PDI)
  • Scrambled RNase A (sRNase A)
  • Three-dimension structural model (3-D structural model)

Background

Protein disulfide isomerase (PDI), a member of thioredoxin-superfamily, plays a key role in catalyzing disulfide bond formation, reduction, and isomerization. It was the first reported protein folding enzyme (Venetianer and Straub 1963a1963b; Goldberger et al. 31963). PDI is best known as resided in endoplasmic reticulum (ER) where folding, modification, and quality control of many secretory and cell-surface proteins take place (Hatahet and Ruddock 2009; Lambert and Freedman 1983). In vivo, native disulfide bond formation involves the formation of new disulfides (oxidation) and the rearrangement of non-native disulfides (isomerization). PDI, contains combinations of catalytically active and inactive thioredoxin domains, is capable of catalyzing both the oxidation of new disulfides and the isomerization of existing disulfides (Kulp et al. 2006). The first and last domains (referred to as a and a’ domain, respectively) contain CxxC active site motifs, whereas the two middle domains (referred to as b and b’ domain) are catalytically inactive (Kemmink et al. 1997). Oxidation, catalyzed by the a’ domain, involves the transfer of an active site disulfide from PDI to substrate proteins. Isomerization, catalyzed by the a domain, requires the active site cysteines to be in the reduced form in order to attack non-native disulfides in substrate proteins thereby catalyzing their rearrangement (Kulp et al. 2006).

Like other proteins with thioredoxin folds, PDI is a multifunctional protein (Pedone et al. 2010). In addition to catalyze protein folding, PDI is the β-subunit of prolyl-4-hydroxylase (Koivu et al. 1987), is a subunit of microsomal triglyceride transfer protein (Wetterau et al. 1991), acts as a chaperone (Wang and Tsou 1993), is implicated in peptide loading onto MHC class I (Peaper and Cresswell 2008), and is involved in regulating NAD(P)H oxidase (Janiszewski et al. 2005). Although members of PDI enzyme have a classic ‘KDEL’ ER retention signal at the C-terminal end (Pelham 1990), the enzymes have been identified outside the ER at many subcellular locations and are known to involve in a wide range of biological functions (Turano et al. 2002). Outside of ER, PDI has been reported to serve as switches for modulating protein function in some cases (Hogg 2003; Wouters et al. 2010). For instance, extracellular PDI mediated disulfide exchange has been shown to switch tissue factor between coagulation to cell signaling (Wouters et al. 2010; Ahamed et al. 2006).

Lemon is an economically valuable produce in Taiwan. It is an amazing fruit that has been used as natural remedy for health and beauty. PDI has been used as an ingredient in cosmetic agents for treating hair (European Patent WO2003099243 A1). Here, we report the cloning of a putative PDI cDNA from lemon, namely ClPDI. The coding region of the ClPDI cDNA was introduced into an E. coli expression system and the active enzyme purified and characterized. Understanding the properties of this ClPDI will be beneficial for its potential applications such as catalyzing protein folding or serving a chaperone contributing to reactivation of inactive enzymes.

Methods

Total RNA preparation from lemon and cDNA synthesis

A fresh lemon (Citrus limonum) was obtained from a local market. The lemon including the skin (4 g) was frozen in liquid nitrogen and ground to powder in a ceramic mortar. PolyA mRNA (35 μg) was prepared using Straight A’s mRNA Isolation System (Novagen, USA). Four μg of the mRNA was used in the 5′-RACE-Ready cDNA and 3′-RACE-Ready cDNA synthesis using Clontech’s SMART RACE cDNA Amplification Kit.

Isolation of ClPDI cDNA

Using the 5′-RACE-Ready cDNA of lemon as a template and two degenerate primers (5′ AGY CAA GGT GCH TTC CAG 3′ and ACY TTM ACW GGC TCR TTG TT), a 0.2 kb fragment was amplified by PCR. The degenerate primers were designed based on the conserved sequences of PDI from AtPDI (Arabidopsis thaliana, AY063059), HsPDI (Homo sapiens, 3F8U_A), MmPDI (Mus musculus, 2DJ2_A), HiPDI (Humicola insolens, 2DJJ_A). The 0.2 kb fragment was subcloned and sequenced. On the basis of this DNA sequence, two primers near both ends, a ClPDI-6R primer (5′ ACY TTM ACW GGC TCR TTG TT 3′) and a ClPDI-7 F primer (5′ GCA CCT TGG GTG AAG GAA TAC 3′) were synthesized. The primers allowed sequence extension from both ends of the 0.2 kb fragment when used with the UPM primer (universal primer A mix, purchased from BD biosciences). Two PCRs were carried out each using 0.1 μg of the 5′-RACE-Ready cDNA or 3′-RACE-Ready cDNA as a template. The primer pairs in each reaction were UPM and ClPDI-6R primers, and UPM and ClPDI-7 F primers. A 1.3 kb fragment (5′-RACE; 5′-DNA end) and a 1.0 kb DNA (3′-RACE; 3′-DNA end) were amplified by PCR. Both DNA fragments were subcloned into pCR4 vector and transformed into E. coli TOPO10. The nucleotide sequences of these inserts were determined in both strands. Sequence analysis revealed that the combined sequences covered an open reading frame of a putative ClPDI cDNA (1828 bp, EMBL no. HM641784). The identity of this ClPDI clone was assigned by comparing the inferred amino acid sequence in various data banks using the basic local alignment search tool (BLAST).

Bioinformatics analysis of ClPDI

The BLASTP program was used to search homologous protein sequences in the nonredundant database (NRDB) at the National Center for Biotechnology Information, National Institutes of Health (http://www.ncbi.nlm.nih.gov/). Multiple alignments were constructed using ClustalW2 program. Protein secondary structure was predicted by SWISS-MODEL program and represented as α helices and β strands. A 3-D structural model of PDI was created by SWISS-MODEL (http://swissmodel.expasy.org/) based on the known crystal structure of Homo sapiens PDI (PDB code 3F8U_A) (Dong et al. 2009). The modeling data was then superimposed with that of PDB ID: 3F8U_A by DeepView Swiss-PdbViewer v4.1 (http://spdbv.vital-it.ch/).

Subcloning of ClPDI cDNA into an expression vector

The coding region of the ClPDI cDNA was amplified using gene specific flanking primers. The 5′ upstream primer contains Eco RI recognition site (5′ CGT CTC GAA TTC GAT GGC CAG TCG ATC GAT 3′) and the 3′ downstream primer contains Not I recognition site (5′ GCG GCC GCG AGC TCA TCT TTT CCA GA 3′). Using 0.2 μg of ClPDI cDNA as a template, and 10 pmole of each 5′ upstream and 3′ downstream primer, a 1.5 kb fragment was amplified by PCR. The fragment was ligated into pCR4 and transformed into E. coli. The recombinant plasmid was isolated and double digested with Eco RI and Not I. The digestion products were separated on a 1.0% agarose gel. The 1.5 kb fragment was gel purified and subcloned into the Eco RI and Not I site of pET-20b(+) expression vector (Novagen). The recombinant DNA was then transformed into E. coli Rosetta (DE3)pLysS and protein expressed by isopropyl β-D-thiogalactopyranoside (IPTG) induction. Expression of functional recombinant protein was demonstrated by enzyme activity assay as described below.

Expression and purification of the recombinant ClPDI

The transformed E. coli containing the ClPDI gene was grown at 37°C in 200 mL of Luria-Bertani containing 50 μg/mL ampicillin until A 600 reached 0.6. Protein expression was induced by the addition of IPTG to a final concentration of 50 μM. The culture was incubated at 80 rpm for an additional 2 h at 32°C. The cells were harvested and soluble proteins extracted in PBS with glass beads as described before (Ken et al. 2005). The recombinant ClPDI was purified by Ni-NTA affinity chromatography (elution buffer: 30% PBS containing 20–250 mM imidazole) as per the manufacture’s instruction (Qiagen). The purified protein was checked by a 10% SDS-PAGE. Protein bands on gel were visualized by staining with Coomassie Brilliant Blue R-250. Protein concentration was determined by a Bio-Rad Protein Assay Kit (Richmond, CA) using bovine serum albumin as a reference standard.

Molecular mass analysis via electrospray ionization quadrupole-time-of-flight (ESI Q-TOF)

The purified recombinant ClPDI (0.21 mg/mL) was prepared in 0.1 mM Tris–HCl containing 0.05 mM NaCl, 0.5 mM imidazole and 0.03% glycerol. The sample (5 μL) was used for molecular mass determination using an ESI Q-TOF mass spectrometer (Micromass, Manchester, England).

ClPDI activity assay

PDI activity was assayed by the method of Ibbetson and Freedman (1976) using scrambled ribonuclease (sRNase A) as a substrate. In this method, PDI was used to activate sRNase A then the ribonuclease activity was monitored spectrophotometriclly as described below. Each 5 μL ClPDI sample (0.2 μg/μL stock solution) was first pre-incubated with 10 μL of 100 μM DTT (dithiothreitol) for 5 min at 25°C. Next, a 0–60 μL portion of the sRNase A (0.036 μM) was added, followed by addition of 10 μL of 0.5 M Tris/HCl, pH 7.5 and appropriate amount of H2O to 90 μL. The mixture was incubated for 20 min at 25°C to allow conversion of sRNase A to active RNase by PDI. The RNase activity was then measured by its ability to degrade RNA. Ten μL of RNA (2 μg/μL) was added to each assay mixture (Total volume was 100 μL). The samples were incubated at 37°C for another 5 min. Three hundred μL of 95% ethanol was added to each assay mixture to precipitate the residual RNA. Ribonuclease activity was monitored by observing the decrease in A 260 of the residual RNA.

Kinetic studies

The kinetic properties of the ClPDI (1.0 μg) was determined by varying the concentrations of sRNase A (3.6 to 21.6 nM) with fixed amount of 20 μg RNA (2 μg/μL). The change in absorbance at 260 nm was recorded between 1 and 20 min. The KM, Vmax and kcat were calculated from Lineweaver-Burk plots.

Enzyme characterization

The ClPDI enzyme was tested for stability in terms of its activity under various conditions. Aliquots of the CIPDI sample (1.0 μg) were treated as follows: (1) Thermal effect. Each enzyme sample (1.0 μg) was heated at 37, 50, 60, 70, or 80°C for 20 min. (2) pH effect. Each enzyme sample (1.0 μg) was adjusted to desired pH by adding a half volume of buffer with different pHs: 0.2 M citrate buffer (pH 2.5, or 4.0), 0.2 M phosphate buffer (pH 6.0, 7.0 or 8.0) or 0.2 M CAPS buffer (pH 10.0, or 11.0). Each sample was incubated at 37°C for 1 h. (3) Imidazole effect. During protein purification, the CIPDI enzyme was eluted with imidazole, therefore, its effect on activity was examined. Imidazole was added to each enzyme sample to the final levels of 0.2, 0.4, 0.8 or 1.0 M and incubated at 37°C for 1 h. (4) DTT effect. DTT was added to each enzyme sample to the final levels of 10, 30, 70, 100 or 200 μM and incubated at 37°C for 5 min. At the end of each treatment, samples were checked for CIPDI activity.

Results and discussion

Cloning and characterization of a cDNA encoding ClPDI

A putative ClPDI cDNA clone was identified on the basis of the consensus pattern and sequence homology to other published PDIs in NCBI database. The entire coding region of ClPDI cDNA is 1503 bp and the deduced protein consists of 500 amino acid residues with a calculated molecular mass of 60.5 kDa (Accession no. HM641784). Figure 1 shows the optimal alignment of the amino acid sequences of the ClPDI with 3 selected ClPDI sequences from other sources. This ClPDI shared 70% identity with AtPDI (Arabidopsis thaliana, AY063059), 35% with HsERp57 (Homo sapiens, NP_005304, 3F8U_A), and 37% with HiPDI (Humicola insolens, AAC60578, 2DJJ_A). The two highly conserved catalytic motifs are denoted in red boxes (C60GHC63, C405GHC408, Figure 1A) located in the two putative catalytic domains, a and a’. The secondary structure, predicted by SWISS-MODEL program, showed 14 α helices and 19 β strands. The structure of PDI is currently recognized as having four distinct domains, a, b, b’, and a’ (as marked in Figure 1A), plus a highly acidic C-terminal extension (which contains the ER-localization motif: KDEL) and an interdomain linker between the b’ and a’ domains (Hatahet and Ruddock 2009; Wang et al. 2010). The 3-D structural model was superimposed with PDB ID: 3F8U_A (orange) via the SPDBV_4 program was shown using protein solid ribbon (Figure 1B).
Figure 1
Figure 1

Alignment of the amino acid sequences of ClPDI with other organism’s PDI and 3-D structural model. (A) Sequence alignment: ClPDI (this study), AtPDI (Arabidopsis thaliana, AY063059), HsPDI (Homo sapiens, P30101), HiPDI (Humicola insolens, AAC60578). Identical amino acids in all sequences are shaded black, conservative replacements are shaded gray. Two red boxes denote highly conserved catalytic motifs (C60GHC63, C405GHC408). Protein secondary structure was predicted by SWISS-MODEL program and represented as α helices and β strands. Underline shows the positions of the domains corresponding to domains a, b, b’ and a’. (B) A 3-D structural model of ClPDI. The structural model of the ClPDI was created based on the known crystal structure of Homo sapiens PDI (PDB: 3F8U_A) via SWISS-MODEL program and was superimposed with PDB ID: 3F8U_A (orange) to obtain structure alignment via SPDBV_4 program.

Expression and purification of the recombinant ClPDI

The coding region of the ClPDI (1503 bp) was amplified by PCR and subcloned into an expression vector, pET-20b (+) as described in the Materials and Methods. Positive clones were verified by DNA sequence analysis. The recombinant ClPDI was expressed, and the proteins were analyzed by a 10% SDS-PAGE in the absence of reducing agent and without boiling (Figure 2). The recombinant ClPDI was not expressed in the absence of IPTG (data not shown). In the presence of IPTG, it was expressed as a His6-tagged fusion protein and was purified by affinity chromatography with nickel chelating Sepharose. A major band of ~63 kDa (expected size of recombinant ClDPI monomer) was detected in Ni-NTA eluted fractions by SDS-PAGE (Figure 2, lanes 5–7). The fractions contained pure protein were pooled and characterized further. Analysis of the ClPDI by ESI Q-TOF confirms the presence of a single protein with molecular mass of 60.5 kDa. This indicates that the enzyme is predominantly monomeric in nature. The yield of the purified His6-tagged ClPDI was 875 μg from 100 mL of culture. Functional ClPDI was detected by activity assay as describe below.
Figure 2
Figure 2

Expression and purification of recombinant ClPDI in E. coli. Fifteen μL (loading buffer without mercaptoethanol and without boiling) of each fraction was loaded into each lane of the 10% SDS-PAGE followed by Coomassie Brilliant Blue R-250 staining. Lane 1, crude extract from E. coli expressing ClPDI; 2, flow-through proteins from the Ni-NTA column; 3, wash; 4–7, ClPDI eluted from Ni-NTA column. Molecular masses (in kDa) of standards are shown at left.

Kinetic studies of the purified ClPDI

The purified recombinant CIPDI possesses PDI activity as demonstrated by its ability to activate sRNase A through oxidation and shuffling of disulfide bonds. Kinetic study of the CIPDI was done by varying substrate concentration of sRNase A. As shown in Figure 3, the Lineweaver-Burk plot of the velocity (1/V) against 1/sRNAase A gave the KM, kcat and kcat/KM values were 8.3 × 10-3 μM, 3.0 × 10-5 min-1, 3.6 × 10-1 min-1 mM-1. Comparison of the KM with that of PDI from other available sources (Table 1) reveals that lemon’s KM is several orders of magnitude smaller. The result indicating that the ClPDI can work under extremely low substrate concentration. The wide variation of KM values among the reported data may due to differences in reaction conditions and whether the redox buffer was sufficiently reducing to maintain PDI in an active form. According to Lambert and Freedman (1983) that the bovine liver PDI requires the presence of either a dithiol or a thiol. Dithiothreitol is effective at concentrations 100-fold lower than that of monothiols such as reduced glutathione or cysteamine. The enzyme follows Michaelis-Menten kinetics with respect to these substrates; KM values were 4, 620 in the presence of reduced glutathione and 380 μM in the presence of DTT. This is one reason to say why animal’s (bovine, and rat) KM values (8 to 380 μM) vary so widely. This reason was also supported by Lyles and Gilbert (1991) that the rat PDI’s catalysis depends on the composition of the redox buffer. The human PDI was assayed using fluorescence-quenched peptides as substrate instead of sRNase A. Therefore, a direct comparison cannot be made.
Figure 3
Figure 3

Double-reciprocal plot of varying ‘scrambled’ ribonuclease A (sRNase A) on ClPDI activity. The initial rate of the enzymatic reaction was measured with change in absorbance at 260 nm between 1 and 20 min at 20 μg RNA with the sRNase A varied from 3.6 to 21.6 nM. The KM, kcat and kcat/KM were calculated from Lineweaver-Burk plots.

Table 1

Kinetic characterization of ClPDI and that from other sources

Species

K M

k cat

kcat/KM

Ref.

(μM)

(min-1)

(min-1 mM-1)

Lemon

8.3 × 10-3

3.0 × 10-5

3.6 × 10-1

This study

Human*

0.21 ~ 2

0.21 ~ 0.89

1 ~ 0.44

Westphal et al. 1998

Bovine

8.0 ± 1.5

0.46 ± 0.05

5.58 × 10-2

Lyles and Gilbert 1991

Bovine

380

NA

NA

Lambert and Freedman 1983

Rat

67 ± 7

1.3 ± 0.1

1.94 × 10-2

Walker and Gilbert 1997

Values for PDI are from this work (lemon) or from the literatures (human, bovine, and rat ).

*Human PDI was assayed using fluorescence-quenched peptides as substrate instead of sRNase A.

The kcat value of ClPDI is also several orders of magnitude smaller than that of PDI from other sources (Table 1). But its kcat/KM value is compatible to that of PDI from other sources. It is likely that the ClPDI is one of the early enzymes that responsible for oxidative folding of proteins in lemon as the enzyme can respond to extremely low substrate concentration.

Characterization of the purified ClPDI

The stability of the enzyme activity was characterized under various conditions. As shown in Figure 4A, thermal stability of the ClPDI was tested to examine the effect of heat on the PDI activity. The purified ClPDI was heat-treated as described in the Materials and Methods and then analyzed for the residue PDI activity. A control reaction where the enzyme was treated at 25°C was counted as 100% activity. The enzyme activity decreased as the temperature increased. There was only 8% detectable activity when the enzyme was heated at 80°C for 20 min. In Figure 4B, the ClPDI is activity under a broad pH range from 6–11 with an optimal activity at pH 8.0. The enzyme retained 30% activity at pH 4.0. The enzyme showed a decrease in its activity with increasing imidazole concentration from 0.2-1 M (Figure 4C). Approximately 70% activity was lost in the presence of 1 M imidazole. The enzyme activity was enhanced in the presence of thiol reducing agent (DTT), the ClPDI activity was correlated with the increasing concentration of DTT from 10 to 100 μM (Figure 4D) and it reached the plateau at approximately 100 μM.
Figure 4
Figure 4

Effect of temperature, pH, imidazole, and DTT on the purified ClPDI. The enzyme sample (1.0 μg) was heated at 37, 50, 60, 70, or 80°C for 20 min. At the end of each treatment, samples were assayed for CIPDI activity at pH 7.5 (A). Aliqouts of the enzyme sample were incubated with different pH buffers at 37°C for 1 h and then assayed for CIPDI activity (B). Imidazole was added to each enzyme sample (1.0 μg) to the final levels of 0.2, 0.4, 0.8 or 1.0 M and incubated at 37°C for 1 h and then assayed for CIPDI activity at pH 7.5 (C). DTT was added to each enzyme sample (1.0 μg) to the final levels of 10, 30, 70, 100 or 200 μM and incubated at 37°C for 5 min and then assayed for CIPDI activity at pH 7.5 (D). Data are means of three experiments.

Conclusion

The importance of PDI has been implicated in health and disease (Benham 2012; Andreu et al. 2012). This study reported the first cloning and expression of an important protein folding enzyme, ClPDI, from lemon. The active form of the ClPDI has been successfully expressed in E. coli and characterized. The advantage of this enzyme over the PDI from all other sources is its extremely low KM. The potential applications of this enzyme in health and beauty may worth pursuing.

Notes

Abbreviations

PDI: 

Protein disulfide isomerase

sRNase A: 

Scrambled RNase A

IPTG: 

Isopropyl β-D-thiogalactopyranoside

SDS-PAGE: 

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis

PBS: 

Phosphate buffer saline.

Declarations

Acknowledgements

This work was supported by the National Science Council of the Republic of China, Taiwan under grant NSC 100-2313-B-019-003-MY3 to C-T. Lin.

Authors’ Affiliations

(1)
Institute of Bioscience and Biotechnology and Center of Excellence for the Oceans, National Taiwan Ocean University, Keelung, Taiwan
(2)
Institute of Genomics and Bioinformatics, Agricultural Biotechnology Center, National Chung Hsing University, Taichung, Taiwan
(3)
Department of Chemistry, Western Illinois University, 1 University Circle, Macomb, USA
(4)
Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan

References

  1. Ahamed J, Versteeg HH, Kerver M, Chen VM, Mueller BM, Hogg PJ, Ruf W: Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 2006, 103: 13932–13937. 10.1073/pnas.0606411103PubMed CentralView ArticlePubMedGoogle Scholar
  2. Andreu CI, Woehlbier U, Torres M, Hetz C: Protein disulfide isomerases in neurodegeneration: from disease mechanisms to biomedical applications. FEBS Lett 2012, 586: 2826–2834. 10.1016/j.febslet.2012.07.023View ArticlePubMedGoogle Scholar
  3. Benham AM: The protein disulfide isomerase family: key players in health and disease. Antioxid Redox Signal 2012, 16: 781–789. 10.1089/ars.2011.4439View ArticlePubMedGoogle Scholar
  4. Dong G, Wearsch PA, Peaper DR, Cresswell P, d Reinisch KM: Insights into MHC class I peptide loading from the structure of the tapasin/ERp57 heterodimer. Immunity 2009, 30: 21–32. 10.1016/j.immuni.2008.10.018PubMed CentralView ArticlePubMedGoogle Scholar
  5. Goldberger RF, Epstein CJ, Anfinsen CB: Acceleration of reactivation of reduced bovine pancreatic ribonuclease by a microsomal system from rat liver. J Biol Chem 1963, 238: 628–635.PubMedGoogle Scholar
  6. Hatahet F, Ruddock LW: Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid & Redox Signaling 2009, 11: 2807–2850. 10.1089/ars.2009.2466View ArticleGoogle Scholar
  7. Hogg PJ: Disulfide bonds as switches for protein function. Trends in Biochem Sci 2003, 28: 210–214. 10.1016/S0968-0004(03)00057-4View ArticleGoogle Scholar
  8. Ibbetson AL, Freedman RB: Thiol-protein disulphide oxidoreductases. Assay of microsomal membrane-bound glutathione-insulin transhydrogenase and comparison with protein disulphide-isomerase. Biochem J 1976, 159: 377–384.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, Santos CXC, Laurindo FRM: Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 2005, 280: 40813–40819. 10.1074/jbc.M509255200View ArticlePubMedGoogle Scholar
  10. Kemmink J, Darby NJ, Dijkstra K, Nilges M, Creighton TE: The folding catalyst protein disulfide isomerase is constructed of active and inactive thioredoxin modules. Curr Biol 1997, 7: 239–245.View ArticlePubMedGoogle Scholar
  11. Ken CF, Hsiung TM, Huang ZX, Juang RH, Lin CT: Characterization of Fe/Mn-superoxide dismutase from diatom Thallassiosira weissflogii : cloning, expression, and property. J Agric Food Chem 2005, 53: 1470–1474. 10.1021/jf048269fView ArticlePubMedGoogle Scholar
  12. Koivu J, Myllyla R, Helaakoski T, Pihlajaniemi T, Tasanen K, Kivirikko KI: A single polypeptide acts both as the β-subunit of prolyl 4-hydroxylase and as a protein disulfide isomerase. J Biol Chem 1987, 262: 6447–6449.PubMedGoogle Scholar
  13. Kulp MS, Frickel EM, Ellgaard L, Weissman JS: Domain architecture of protein-disulfide isomerase facilitates its dual role as an oxidase and an isomerase in Ero1p-mediated disulfide formation. J Biol Chem 2006, 281: 876–884.View ArticlePubMedGoogle Scholar
  14. Lambert N, Freedman RB: Kinetics and specificity of homogeneous protein disulphide-isomerase in protein disulphide isomerization and in thiol-protein-disulphide oxidoreduction. Biochem J 1983, 213: 235–243.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Lyles MM, Gilbert HF: Catalysis of the oxidative folding of ribonuclease A by protein disulfide isomerase: dependence of the rate on the composition of the redox buffer? Biochemistry 1991, 30: 613–619. 10.1021/bi00217a004View ArticlePubMedGoogle Scholar
  16. Peaper DR, Cresswell P: Regulation of MHC class I assembly and peptide binding. Annu Rev Cell Dev Biol 2008, 24: 343–368. 10.1146/annurev.cellbio.24.110707.175347View ArticlePubMedGoogle Scholar
  17. Pedone E, Limauro D, D’Ambrosio K, De Simone G, Bartolucci S: Multiple catalytically active thioredoxin folds: a winning strategy for many functions. Cell Mol Life Sci 2010, 67: 3797–3814. 10.1007/s00018-010-0449-9View ArticlePubMedGoogle Scholar
  18. Pelham HR: The retention signal for soluble proteins of the endoplasmic reticulum. Trends Biochem Sci 1990, 15: 483–486. 10.1016/0968-0004(90)90303-SView ArticlePubMedGoogle Scholar
  19. Turano C, Coppari S, Altieri F, Ferraro A: Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol 2002, 193: 154–163. 10.1002/jcp.10172View ArticlePubMedGoogle Scholar
  20. Venetianer P, Straub FB: Enzymic formation of the disulfide bridges of ribonuclease. Acta Physiol Acad Sci Hung 1963, 24: 41–53.PubMedGoogle Scholar
  21. Venetianer P, Straub FB: The enzymatic reactivation of reduced ribonuclease. Biochim Biophys Acta 1963, 67: 166–168.View ArticlePubMedGoogle Scholar
  22. Walker KW, Gilbert HF: Scanning and escape during protein-disulfide isomerase assisted protein folding. J Biol Chem 1997, 272: 8845–8848. 10.1074/jbc.272.14.8845View ArticlePubMedGoogle Scholar
  23. Wang CC, Tsou CL: Protein disulfide isomerase is both an enzyme and a chaperone. FASEB J 1993, 7: 1515–1517.PubMedGoogle Scholar
  24. Wang C, Chen S, Wang X, Wang L, Wallis AK, Freedman RB, Wang CC: Plasticity of human protein disulfide isomerase evidence for mobility around the x-linker region and its functional significance. J Biol Chem 2010, 285: 26788–26797. 10.1074/jbc.M110.107839PubMed CentralView ArticlePubMedGoogle Scholar
  25. Westphal V, Spetzler JC, Meldal M, Christenseni U, Winther JR: Kinetic analysis of the mechanism and specificity of protein disulfide isomerase using fluorescence-quenched peptides. J Biol Chem 1998, 273: 24992–24999. 10.1074/jbc.273.39.24992View ArticlePubMedGoogle Scholar
  26. Wetterau JR, Combs KA, McLean LR, Spinner SN, Aggerbeck LP: Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein. Biochemistry 1991, 30: 9728–97235. 10.1021/bi00104a023View ArticlePubMedGoogle Scholar
  27. Wouters MA, Fan SW, Haworth NL: Disulfides as redox switches: from molecular mechanisms to functional significance. Antioxid & Redox Signal 2010, 12: 53–91. 10.1089/ars.2009.2510View ArticleGoogle Scholar

Copyright

© Chen et al.; licensee Springer. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement